セッション情報

International Session(Oral)

第52回・2014年・横浜
International Session(Oral)
International Session 1
Biomaker of GI tract
開催回
第52回・2014年・横浜

CXCR4 and c-Met signaling and might be a candidate target for the treatment of scirrhous gastric cancer

演題番号 : ISO1-1

Kinoshita Haruhito:1、Yashiro Masakazu:1、Masuda Go:1、Kasahima Hiroaki:1、Tamami Morisaki:1、Fukuoka Tatsunari:1、Hirakawa Kosei:1

1:Department of Surgical Oncology, Graduate School, Osaka City University

CXCR4 and c-Met signaling and might be a candidate target for the treatment of scirrhous gastric cancer

Nuclear HSP110 expression is associated with chemo-sensitivity in gastric cancer patients

演題番号 : ISO1-2

Kimura Akiharu:1、Yokobori Takehiko:1、Bolag Altan:1、Kogure Norimichi:1、Suzuki Masaki:1、Toyomasu Yoshitaka:1、Ogata Kyoichi:1、Kuwano Hiroyuki:1

1:Department of General Surgical Science, Graduate School, Gunma University

Nuclear HSP110 expression is associated with chemo-sensitivity in gastric cancer patients

Prognostic Impact of Autophagy Substrate p62 Expression in Gastric Cancer

演題番号 : ISO1-3

Masuda Go:1、Yashiro Masakazu:1、Kasashima Hiroaki:1、Kinoshita Haruhito:1、Morisaki Tamami:1、Fukuoka Tatsunari:1、Sakurai Katsunobu:1、Kubo Naoshi:1、Muguruma Kazuya:1、Ohira Masaichi:1、Hirakawa Kosei:1

1:Department of Surgical Oncology, Graduate School of Medicine, Osaka City University

Prognostic Impact of Autophagy Substrate p62 Expression in Gastric Cancer

LOXL2 might be a promising target for the treatment of gastric cancer

演題番号 : ISO1-4

Kasashima Hiroaki:1、Yashiro Masakazu:1、Go Yukie:1、Masuda Go:1、Kinoshita Haruhito:1、Tokumoto Mao:1、Morisaki Tamami:1、Fukuoka Tatsunari:1、Sakurai Katsunobu:1、Toyokawa Takahiro:1、Kubo Naoshi:1、Tanaka Hiroaki:1、Muguruma Kazuya:1、Ohira Masaichi:1、Hirakawa Kosei:1

1:Surgical oncology, Graduate School of Medicine, Osaka City University

LOXL2 might be a promising target for the treatment of gastric cancer

Clinical significance of high risk macroscopic appearance (Type Ⅳ and large Type Ⅲ) in advanced gastric cancer with standard treatment (curative surgery and S1 administration)

演題番号 : ISO1-5

Yamashita Keishi:1、Mieno Hiroaki:1、Ema Akira:1、Hosoda Kei:1、Moriya Hiromitsu:1、Katada Natsuya:1、Kikuchi Shiro:1、Watanabe Masahiko:1

1:Sugery, Kitasato University, East Hospital

Clinical significance of high risk macroscopic appearance (Type Ⅳ and large Type Ⅲ) in advanced gastric cancer with standard treatment (curative surgery and S1 administration)

Somatic mutation profiling in the RAS-RAF signal cascade: promising predictive markers for extra-hepatic spreading in colorectal liver metastases

演題番号 : ISO1-6

Umeda Yuzo:1、Nagasaka Takeshi:1、Mori Yoshiko:1、Yoshida Kazuhiro:1、Taniguchi Fumitaka:1、Fuji Tomokazu:1、Shinoura Susumu:1、Yoshida Ryuichi:1、Nobuoka Daisuke:1、Yagi Takahito:1、Fujiwara Toshiyoshi:1

1:Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Somatic mutation profiling in the RAS-RAF signal cascade: promising predictive markers for extra-hepatic spreading in colorectal liver metastases